Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13,612Revenue (TTM) $M14,358Net Margin (%)2.5Altman Z-Score2.1
Enterprise Value $M21,248EPS (TTM) $1.7Operating Margin %10.1Piotroski F-Score6
P/E(ttm)38.7Beneish M-Score-2.8Pre-tax Margin (%)7.3Higher ROA y-yN
Price/Book2.910-y EBITDA Growth Rate %11.7Quick Ratio1.6Cash flow > EarningsY
Price/Sales1.05-y EBITDA Growth Rate %9.4Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow10.9y-y EBITDA Growth Rate %16.6ROA % (ttm)1.9Higher Current Ratio y-yN
Dividend Yield %--PEG4.2ROE % (ttm)7.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M207ROIC % (ttm)5.7Gross Margin Increase y-yN

Gurus Latest Trades with DVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAArnold Van Den Berg 2016-06-30 Reduce-3.14%$73.03 - $77.93
($75.54)
$ 65.46-13%Reduce -75.89%79,300
DVAJoel Greenblatt 2016-06-30 Sold Out -0.42%$73.03 - $77.93
($75.54)
$ 65.46-13%Sold Out0
DVAMario Gabelli 2016-06-30 Reduce$73.03 - $77.93
($75.54)
$ 65.46-13%Reduce -2.89%40,363
DVAArnold Van Den Berg 2016-03-31 Add0.76%$62.24 - $73.38
($67.47)
$ 65.46-3%Add 22.67%328,908
DVAJoel Greenblatt 2016-03-31 Add0.17%$62.24 - $73.38
($67.47)
$ 65.46-3%Add 69.62%513,100
DVAMario Gabelli 2016-03-31 Add$62.24 - $73.38
($67.47)
$ 65.46-3%Add 4.00%41,563
DVASteve Mandel 2015-12-31 Sold Out -2.41%$67.79 - $78.16
($73.23)
$ 65.46-11%Sold Out0
DVAArnold Van Den Berg 2015-12-31 Reduce-0.22%$67.79 - $78.16
($73.27)
$ 65.46-11%Reduce -6.22%268,133
DVAJoel Greenblatt 2015-12-31 Add0.19%$67.79 - $78.16
($73.23)
$ 65.46-11%Add 525.25%302,502
DVAMario Gabelli 2015-12-31 Reduce$67.79 - $78.16
($73.23)
$ 65.46-11%Reduce -4.31%39,963
DVAArnold Van Den Berg 2015-09-30 Add1.63%$70.93 - $81.14
($77.54)
$ 65.46-16%Add 85.75%285,918
DVASteve Mandel 2015-09-30 Add0.75%$70.93 - $81.14
($77.54)
$ 65.46-16%Add 45.15%7,918,998
DVAJoel Greenblatt 2015-09-30 Buy 0.03%$70.93 - $81.14
($77.54)
$ 65.46-16%New holding48,381
DVAArnold Van Den Berg 2015-06-30 Reduce-0.11%$79.47 - $84.23
($82.11)
$ 65.46-20%Reduce -5.86%153,928
DVAMario Gabelli 2015-06-30 Add$79.47 - $84.23
($82.11)
$ 65.46-20%Add 5.29%41,763
DVAArnold Van Den Berg 2015-03-31 Buy 1.87%$72.78 - $82.84
($76.74)
$ 65.46-15%New holding163,503
DVASteve Mandel 2015-03-31 Add0.47%$72.78 - $82.84
($76.74)
$ 65.46-15%Add 38.47%5,455,774
DVAJoel Greenblatt 2015-03-31 Sold Out -0.22%$72.78 - $82.84
($76.74)
$ 65.46-15%Sold Out0
DVAMario Gabelli 2015-03-31 Reduce$72.78 - $82.84
($76.74)
$ 65.46-15%Reduce -7.25%39,663
DVASteve Mandel 2014-12-31 Buy 1.3%$72.03 - $78.07
($75.35)
$ 65.46-13%New holding3,940,169
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2016-08-09Sell20,262$73.09-10.02view
JIGANTI JEANINE MARIEChief Compliance Officer 2016-07-11Sell1,291$78.51-16.23view
JIGANTI JEANINE MARIEChief Compliance Officer 2016-07-01Sell4,620$77.45-15.08view
Arway Pamela MDirector 2016-05-25Sell10,824$77.16-14.76view
HILGER JAMES KInterim CFO and CAO 2016-05-23Sell3,416$76.79-14.35view
THIRY KENT JChairman and CEO 2016-05-20Sell32,880$76.99-14.57view
Kogod DennisPres, HCP & CEO, DVA Int. 2016-05-17Sell17,700$77.35-14.97view
ZUMWALT LEANNE MGrp VP, Purch & Public Affairs 2016-05-17Sell538$77.08-14.67view
HILGER JAMES KInterim CFO and CAO 2016-05-16Sell3,983$75.59-12.99view
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2016-05-16Sell4,934$75.69-13.11view

Press Releases about DVA :

Quarterly/Annual Reports about DVA:

News about DVA:

Articles On GuruFocus.com
Baxter Well Positioned in Fast-Growing Market for Kidney Dialysis Equipment Jul 01 2016 
Arnold Van Den Berg's Largest Buys in 1st Quarter Apr 21 2016 
Weekly CEO Sells Highlights Apr 18 2016 
7 High Quality Guru Stocks Apr 11 2016 
Steve Mandel Sells Health Care Stakes Mar 11 2016 
Undervalued, Predictable Companies Include Monsanto and Western Union Mar 10 2016 
Alan Fournier Makes Modest Reductions in Middleby and Priceline Jan 12 2016 
Allergan Among Health Care Holdings in Alan Fournier's Portfolio Dec 15 2015 
Starting With GAAP Jun 11 2015 
Berkshire Hathaway: Business Value Exceeds Market Value May 26 2015 

More From Other Websites
ETF’s with exposure to DaVita, Inc. : September 28, 2016 Sep 28 2016
Over 500 Cyclists Ride in 10th Annual Tour DaVita to Raise Funds and Awareness for Kidney Disease Sep 23 2016
Edwards Lifesciences, DaVita HealthCare Partners, Corcept Therapeutics and CryoLife highlighted as... Sep 22 2016
Bear of the Day: DaVita HealthCare Partners (DVA) Sep 22 2016
DaVita Kidney Care Celebrates First Day of Autumn with Slow Cooker Cookbook Sep 22 2016
DaVita upgraded by Raymond James Sep 20 2016
DaVita Names New President for Florida Medical Group Operations Sep 14 2016
DAVITA INC. Financials Sep 09 2016
DAVITA INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,... Sep 08 2016
DAVITA INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,... Sep 06 2016
Citi Initiates DaVita Healthcare At Neutral: 'Living DaVita Loca?' Sep 06 2016
The Everett Clinic Announces Leadership Transitions Aug 30 2016
DaVita Kidney Care Welcomes Dr. Bryan Becker to Physician Leadership Team Aug 30 2016
DaVita Celebrates Recent Awards Aug 25 2016
DaVita affiliate proposes Lockport's first dialysis clinic Aug 25 2016
Modern Healthcare magazine details Colorado's top health-care power brokers Aug 24 2016
ETF’s with exposure to DaVita HealthCare Partners, Inc. : August 24, 2016 Aug 24 2016
DaVita Kidney Care Welcomes Dr. Jeff Giullian to Physician Leadership Team Aug 23 2016
Sunday links: identifying talents Aug 21 2016
Fallout from Obamacare probe as shares of dialysis firms drop Aug 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)